ASMI welcomes new Complementary Medicines Regulatory Manager

04 June 2014

Return to Media Release Index

4 June 2014 - The Australian Self Medication Industry (ASMI) today welcomed Annaliese Scholz as its new Regulatory and Technical Manager for Complementary Medicines.
ASMI Director of Regulatory and Scientific Affairs Steve Scarff said: "Annaliese brings a wealth of technical and regulatory knowledge to ASMI and will be a great asset to ASMI members. She has worked in a variety of complementary medicine organisations over the years and has a strong background in regulatory affairs, pharmacovigilance, product development and quality assurance.

"This is an exciting time for Annaliese to be joining ASMI as there is substantial regulatory reform underway in the complementary medicines arena. She will represent ASMI members on a number of committees and participate in public policy processes on a range of issues.

"Annaliese will assist members to understand regulatory, compliance and political issuesaffecting the sector and provide them with advice on day-to-day issues. She will also provide technical and regulatory support to ASMI's Strategy Manager - Complementary Medicines.

"I am confident that Annaliese's academic qualifications in science and naturopathy together with her industry experience will equip her to make a great contribution to ASMI and ASMI members," said Mr Scarff.

About ASMI: The Australian Self Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines. Its members make up 85 per cent of the $4bn self care market. Membership totals 60 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to promote better health through responsible self care. This means ensuring that safe and effective self care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy.

For more information or to arrange a media interview, please contact:
Marie Kelly-Davies
PR Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: